- ModifierDescription
- E1Upper left, eyelid
- E2Lower left, eyelid
- E3Upper right, eyelid
- E4Lower right, eyelid
- EAErythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer chemotherapy
- EBErythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy
- ECErythropoetic stimulating agent (esa) administered to treat anemia not due to anti-cancer radiotherapy or anti-cancer chemotherapy
- EDHematocrit level has exceeded 39% (or hemoglobin level has exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle
- EEHematocrit level has not exceeded 39% (or hemoglobin level has not exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle
- EJSubsequent claims for a defined course of therapy, e.g., epo, sodium hyaluronate, infliximab
- EMEmergency reserve supply (for esrd benefit only)
- EPService provided as part of medicaid early periodic screening diagnosis and treatment (epsdt) program
- ERItems and services furnished by a provider-based, off-campus emergency department
- ETEmergency services
- EXExpatriate beneficiary
- EYNo physician or other licensed health care provider order for this item or service